The Swiss Competition Authority imposes fines on three pharmaceutical companies for resale price maintenance (Pfizer, Lilly, Bayer)

According to a press release of 1 December 2009, the Swiss Competition Authority has imposed fines totaling approximately € 3.7

Access to this article is restricted to subscribers

Already Subscribed? Sign-in

Access to this article is restricted to subscribers.

Read one article for free

Sign-up to read this article for free and discover our services.

 

PDF Version

Author

  • Van Bael & Bellis (Brussels)

Quotation

Andrzej Kmiecik, The Swiss Competition Authority imposes fines on three pharmaceutical companies for resale price maintenance (Pfizer, Lilly, Bayer), 1 December 2009, e-Competitions Bulletin December 2009, Art. N° 41675

Visites 252

All issues

  • Latest News issue 
  • All News issues
  • Latest Special issue 
  • All Special issues